find your role first. Sign in

Raises

EndoSure raises $1.3M in November 2026 SEC filing

EndoSure
Raised in SEC filings
$1.5M
Filings
2
Latest est. round
Seed
Incorporated
2022
Industry
Health care
Based in
MD

EndoSure, an Other Health Care company based in MD, first filed with the SEC in February 2025, reporting a $150K raise with a first sale date of February 5, 2025. This was an estimated Pre-seed/Seed round. All rounds are estimates.

The company filed again in November 2026, reporting a $1.3M raise with a first sale date of November 3, 2026. This was an estimated Seed round. The amount raised increased from the previous filing.

The latest filing names Mark Noar as an Executive Officer and Director, Mark November as a Director, and Carlos Babini as an Executive Officer and Director. We do not track EndoSure's open roles yet.

Every Form D filing

First saleAmount soldEst. round
2026-11-03$1.3MSeed
2025-02-05$150KPre-seed/Seed

Named in the latest filing

From SEC Form D filings. Rounds are our estimate from the amount sold; filings carry no valuation. All filings on SEC EDGAR

Get this in your inbox

The daily read on who's hiring and who just raised, or one email a week. Free, one click to stop.